Researchers at Tianjin Medical University announced findings that suggest Type 2 diabetes mellitus with mild cognitive impairment accelerated progression to dementia by 2.74 years.
Findings by University of Montana Professor Dr. Lilian Calderón-Garcidueñas, MA, MD, Ph.D., and her team of researchers reveal that children living in megacities are at increased risk for brain inflammation and neurodegenerative changes, including Alzheimer’s or Parkinson’s disease.
In a large population-based study of randomly selected participants in Germany, researchers found that mild cognitive impairment occurred twice more often in individuals diagnosed with diabetes mellitus type 2.
Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer’s disease, a recent study from neuroscientists at the University of South Florida shows.
Research published in JAD suggests healthy older adults are less capable of observing their own cognitive decline over an 18 month period than Cogstate’s computerized brief battery (CBB). The study also indicated that close family members were unable to perceive decline in the cognitive behavior of their partner in social settings.
Rresearchers at the Blanchette Rockefeller Neurosciences Institute (BRNI) announced findings from a new study that offer significant promise for a new therapeutic and diagnostic approach to Alzheimer's disease (AD) that has remained so refractory to effective and early drug treatment.
No front page content has been created yet.